Formative Study of Tailored Survivor Health Promotion
1 other identifier
observational
15
1 country
3
Brief Summary
The overall goal of this study is to explore colorectal cancer patients' concerns and interest about their health and behavior changes post treatment. Investigators will conduct formative research, which includes qualitative interviews, to assess the issues that cancer survivors are willing to work on as they transition out of active treatment. The specific aims are as follows: Aim 1: Use qualitative interview methods to describe the taxonomy of domains health promotion and illness prevention behavior changes for which colorectal cancer survivors need new information, skills training and support. Aim 2: Explore colorectal cancer patients' perceptions of their post treatment functional status. Aim 3: Explore the impact of cancer, treatment, and co-morbidities on colorectal cancer patients' health goals and functional status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2008
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 15, 2009
CompletedFirst Posted
Study publicly available on registry
January 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedMarch 9, 2015
March 1, 2015
5.9 years
January 15, 2009
March 6, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colorectal Cancer Patients' Concerns + Behavior Changes Post Treatment
Qualitative data collection over 2 years
Study Arms (1)
Cancer Survivorship Study
Survey of colorectal cancer patients within one year from treatment end.
Interventions
One-time questionnaire + recorded qualitative interview, approximately 45 minutes total.
Eligibility Criteria
Stage IIB or III Colorectal cancer patients over 18 years of age ending cancer treatment or have completed cancer treatment.
You may qualify if:
- Patient with Stage IIB or III colorectal cancer.
- Men and women within 1 year of ending primary treatment for colorectal cancer.
- Over 18 years of age.
- Must be able to read and write English.
- Must be able to understand and provide written informed consent.
You may not qualify if:
- \) Patients who have had previous treatment for cancer before treatment at M.D. Anderson, Kelsey-Seybold, and the VA Medical Center.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Kelsey Research Foundation
Houston, Texas, 77005, United States
The Michael E. DeBakey VA Medical Center, Baylor College of Medicine
Houston, Texas, 77030, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Holly Holmes, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2009
First Posted
January 19, 2009
Study Start
December 1, 2008
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
March 9, 2015
Record last verified: 2015-03